ImmunoPrecise Sells Netherlands Unit to Boost AI-Driven Innovation
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a biotherapeutics company delivering advanced solutions in biologics and drug discovery, today announced the successful sale...